Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 6 Aug 2025 | 1 Aug 2025 |
Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve unaudited financial results for Q-1 FY26 Q1 FY26 Results and Others Please find attached the Q1-FY 26 Unaudited Financial Results (As Per BSE Announcement Dated on :06.08.2025) | ||
Board Meeting | 21 Jun 2025 | 21 Jun 2025 |
Re-appointment of Mrs. (Dr.) Savita as an Independent Director for a second term of 5 years | ||
Board Meeting | 12 May 2025 | 5 May 2025 |
Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Financial Results Q4 & FY25 and recommend final dividend if any for the financial year ended March 31 2025 Outcome of Board meeting held on May 12, 2025 Approved the final dividend of Rs. 0.20/- per equity share of the face value of Rs. 2/- each for the financial year ended March 31, 2025, subject to approval of the members of the Company at the ensuing Annual General Meeting (As Per BSE Announcement Dated on :12.05.2025) | ||
Board Meeting | 28 Apr 2025 | 28 Apr 2025 |
Please find attached the file | ||
Board Meeting | 6 Feb 2025 | 3 Feb 2025 |
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended December 31 2024. Please find attached results and LLR - Q3 FY 25 (As Per BSE Announcement dated on 06.02.2025) | ||
Board Meeting | 14 Jan 2025 | 14 Jan 2025 |
Please find attached outcome of Board Meeting. | ||
Board Meeting | 11 Nov 2024 | 6 Nov 2024 |
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended on September 30 2024. Please find attached results and LLR - Q2 FY 25 (As Per BSE Announcement Dated on 11.11.2024) | ||
Board Meeting | 27 Aug 2024 | 27 Aug 2024 |
Please find enclosed letter comprising outcome of board meeting held on 27-August-2024. Please find enclosed update on disclosure submitted on August 27, 2024. (As per BSE Announcement Dated on 14/10/2024) |
With this approval, Morepen Laboratories aims to strengthen its presence in China, which is one of the world’s largest pharmaceutical markets.
Developed from scratch, this drug offers an inexpensive and superior alternative to current treatments, making it accessible to hundreds of millions of patients.
Here are some of the stocks that may see significant price movement today: Tata Motors, ITC, Kalyan Jewellers, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.